Clinical Trial Update: FAST Fish Phase IIb Clinical Trial for the Treatment of Fish Allergy by Subcutaneous Immunotherapy [Phase 2]

View source ↗

Summary

The FAST Fish Phase IIb trial evaluating subcutaneous immunotherapy for fish allergy has completed its Phase 2 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fish Allergy

Drugs mentioned

• FAST-Fish

Snippet

Sponsor: George Stavroulakis | Conditions: Food Allergy to Fish | Phase 2 | Status: COMPLETED